High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs

Table 2 Distribution of the development of distant metastases and breast cancer-related deaths according to tumor-infiltrating lymphocytes and platelet-to-lymphocyte ratio

	n	Met	P value	Death	P value
Group 1 (TIL-high/PLR-low)	31	1 (3.2%)		1 (3.2%)
Group 2 (TIL-high/PLR-high)	43	5 (11.6%)	0.026^a	4 (9.3%)	0.022^a
Group 3 (TIL-low/PLR-low)	60	11 (18.3%)	0.026^a	7 (11.7%)	0.022^a
Group 4 (TIL-low/PLR-high)	42	12 (28.6%)		11 (26.2%)

^aComparisons among the four groups
Met patients who developed distant metastases, PLR platelet-to-lymphocyte ratio, TIL tumor-infiltrating lymphocytes

ISSN: 1465-542X